The short answer
It is not established that Herba Taraxaci adds to chlorothiazide-related low blood pressure or requires a fixed dosing gap. The available dandelion evidence concerns different preparations and does not test this combination.
What this answer covers
Herba Taraxaci herb-material entry; confirm species and parts. Fresh leaf extract and root-with-herb are not automatically the same product.
- Supplement or preparation
- Herba Taraxaci
- Medication ingredient
- chlorothiazide
Traditional urinary use does not prove hypotension
The European monograph concerns dandelion root combined with herb and reports no interactions. Its urinary-flushing use is traditional and does not demonstrate a blood-pressure interaction with chlorothiazide.
The leaf pilot has narrow findings
A small uncontrolled study tested fresh leaf extract for one day. Some urinary measures increased after the first two doses, with no change after the third. It did not test chlorothiazide, low blood pressure or the full range of Herba Taraxaci products.
Fluid balance is still worth reviewing
Chlorothiazide’s effects can become excessive and cause dehydration or hypotension. This supports checking a product intended to increase urination, without converting an uncertain herb effect into proven additive hypotension.
No proven spacing rule
A short dosing gap has not been shown to prevent a possible fluid effect. Tell the treating team about new urinary or weight-loss products, dizziness, faintness, marked thirst or reduced fluid intake. Chlorothiazide can itself cause excess fluid loss and kidney problems. Follow your existing fluid plan rather than increasing fluids or changing chlorothiazide on your own.
Evidence and practical considerations
Timing & monitoring
No universal avoidance or protective spacing interval demonstrated. A narrower intake, preparation and clinical monitoring precaution may be appropriate.
- Exact scope
- Herba Taraxaci herb-material entry; confirm species and parts. Fresh leaf extract and root-with-herb are not automatically the same product. with Oral chlorothiazide, exact RxCUI2396 IN. No automatic transfer from loop diuretics or another thiazide.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No universal risk rate or spacing interval; individual source limitations apply.
Factors that may matter: Preparation and plant part; Dose and duration; Kidney function; Fluid status; Other medicines; Calcium or potassium status.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People treated with oral chlorothiazide
Can cause fluid and electrolyte disturbances, including low potassium and sodium. Reduces urinary calcium excretion and can raise serum calcium; substantial elevation needs evaluation.
How this applies: Exact medication, salt, route, plant part, formulation and clinical endpoint govern applicability.
Exact oral product; not another thiazide or loop diuretic. Chlorothiazide sodium intravenous therapy is a separate route and salt. THALITONE has product-specific bioavailability and should not be assumed dose-for-dose identical to other formulations.
Source 2: regulatory guidance
ema.europa.eu · Source check Sep 10, 2026
Population: People using the specified oral preparation.
Traditional urinary-flushing use; no interactions reported.
How this applies: Interpret only for the stated species, preparation, route and endpoints; exact chlorothiazide pair evidence is distinguished.
Not identical to Herba Taraxaci alone and not proof of chlorothiazide-associated hypotension.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 17 volunteers.
Urination frequency increased after the first dose and urine-to-fluid ratio after the second; no change after the third dose.
How this applies: Interpret only for the stated species, preparation, route and endpoints; exact chlorothiazide pair evidence is distinguished.
Uncontrolled pilot, no chlorothiazide or blood-pressure interaction endpoint; leaf extract is not every Herba Taraxaci product.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact-pair article with separately verified drug label, original human evidence and explicit preparation and endpoint limitations. | |
| Research summary published |
Article revision: 087c9a0f7dd829e8
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.